Inovio

  • Funded by Coalition for Epidemic Preparedness Innovations (CEPI)
  • Total publications:1000 publications

Grant number: N/A

Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $22,500,000
  • Funder

    Coalition for Epidemic Preparedness Innovations (CEPI)
  • Principal Investigator

    Kate Broderick
  • Research Location

    United States of America
  • Lead Research Institution

    Inovio
  • Research Priority Alignment

    N/A
  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Phase 1 clinical trial

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Clinical Trial, Phase I

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

DNA plasmid with electroporation, coding for full-length spike protein of SARS-CoV-2 Phase I/II

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy.

Clinical outcomes and independently adjudicated results of M2 aspiration thrombectomy: a subgroup analysis from the Imperative Trial.

Neuropeptide-mediated synaptic plasticity regulates context-dependent mating behaviors in Drosophila.

Topology and kinetic pathways of colloidosome assembly and disassembly.

Neuraxial anesthesia use in revision hip and knee arthroplasties: impact of periprosthetic joint infection and temporal trends.

Atomic armor for thermal stability in nanoporous structures.

Photochemical Production of Singlet Oxygen by Toronto Road Dust.

Finding the dark matter: Large language model-based enzyme kinetic data extractor and its validation.